微小残存病変のトップ企業
-
Adaptive Biotechnologies
-
Bristol-Myers Squibb
-
Kite Pharma
-
Natera
-
Amgen
*免責事項:上位企業は順不同
微小残存病変 - 競争の集中度
微小残存病変企業一覧
-
Adaptive Biotechnologies
-
Bristol-Myers Squibb Company
-
Amgen Inc.
-
Kite Pharma
-
Natera
-
SYNIMMUNE GmbH
-
Navidea Biopharmaceuticals
-
Novartis
-
AstraZeneca
-
iRepertoire